PR Newswire August 27, 2019
New Chilmark Research report examines recent progress in precision medicine, as well as IT challenges and emerging solutions to enable mainstream adoption
BOSTON, Aug. 27, 2019 /PRNewswire/ — The All of Us research program, CAR-T therapies, increasingly accessible genetic testing, and other applications for new medical data are all starting to make the concept of precision medicine a reality. As these new data-driven, personalized treatment plans begin to enter clinical practice in specialty care settings such as oncology and mental health, it is time to assess the limits of current health IT ecosystems to broader clinical adoption, and where the opportunities lie for innovative solutions to bring precision medicine into the mainstream.
In a new report, Precision Medicine and Health...
Today's Sponsors
Today's Sponsor